To this end, attenuating the expression of these identified candidate genes in tumors can potentially enhance the infiltration of CD8+ T cells and B cells and decrease the infiltration of CD4+ T cells and macrophages, which would be a promising direction for improving patient outcomes and developing targeted therapeutics for HNSCC. Here, CD4 is linked to head and neck squamous cell carcinoma.